Journal of Cataract & Refractive Surgery
Volume 34, Issue 5 , Pages 735-742, May 2008

Long-term effects of phacoemulsification with intraocular lens implantation in normotensive and ocular hypertensive eyes

From Volunteers in Medicine (Poley), Hilton Head, South Carolina, and a private practice (Lindstrom, Samuelson), Minneapolis, Minnesota, USA

Accepted 10 December 2007.

Purpose

To evaluate the long-term effect of phacoemulsification with intraocular lens (IOL) implantation alone in normotensive and ocular hypertensive eyes.

Setting

Private practices, Minneapolis, Minnesota, and Savannah, Georgia, USA.

Methods

The IOP before surgery, 1 year after surgery, and at the final chart recording in 588 eyes having phacoemulsification with IOL implantation was retrospectively reviewed. Before surgery, eyes were divided into 5 groups based on IOP at surgery, patient age at surgery, years of postoperative follow-up, and a comparison between IOP at 1 year and IOP at the final check.

Results

The final mean IOP reduction was 6.5 mm Hg (27%) in the 31 to 23 mm Hg presurgical IOP group (n = 19), 4.8 mm Hg (22%) in the 22 to 20 mm Hg group (n = 62), 2.5 mm Hg (14%) in the 19 to 18 mm Hg group (n = 86), and 1.6 mm Hg (9%) in the 17 to 15 mm Hg group (n = 223). In the 14 to 9 mm Hg group (n = 198), the mean IOP at the final examination was 0.2 mm Hg higher (0.1% increase).

Conclusions

Stratifying eyes according to presurgical IOP showed greater long-term IOP reductions than previously reported. The reduction was proportional to the presurgical IOP. The decrease was greatest in eyes with the highest presurgical IOP. The IOP remained unchanged in eyes with the lowest presurgical IOP. The IOP reductions at 1 year were sustained over 10 years and were similar in patients of all ages.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Lindstrom is a consultant to Alcon, AMO, Glaukos, and Bausch & Lomb. Dr. Samuelson is a consultant to AMO, iScience, Glaukos, Transcend Medical, and Denali Medical. No author has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(08)00204-6

doi:10.1016/j.jcrs.2007.12.045

Journal of Cataract & Refractive Surgery
Volume 34, Issue 5 , Pages 735-742, May 2008